Leerink Partnrs Expects Higher Earnings for Tenet Healthcare

featured-image

Tenet Healthcare Co. (NYSE:THC – Free Report) – Leerink Partnrs upped their Q2 2025 earnings per share (EPS) estimates for shares of Tenet Healthcare in a research note issued to investors on Thursday, April 24th. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn $2.62 per share for the quarter, up from [...]

Tenet Healthcare Co. ( NYSE:THC – Free Report ) – Leerink Partnrs upped their Q2 2025 earnings per share (EPS) estimates for shares of Tenet Healthcare in a research note issued to investors on Thursday, April 24th. Leerink Partnrs analyst W.

Mayo now forecasts that the company will earn $2.62 per share for the quarter, up from their prior forecast of $2.60.



The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Leerink Partnrs also issued estimates for Tenet Healthcare’s Q3 2025 earnings at $2.

75 EPS, Q4 2025 earnings at $3.47 EPS and FY2027 earnings at $15.92 EPS.

THC has been the topic of several other research reports. StockNews.com upgraded shares of Tenet Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, March 13th.

TD Cowen initiated coverage on shares of Tenet Healthcare in a report on Wednesday, February 26th. They set a “buy” rating and a $175.00 target price on the stock.

Truist Financial lowered their price target on Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating for the company in a report on Monday, January 6th.

Robert W. Baird reaffirmed a “neutral” rating and issued a $137.00 target price (down previously from $153.

00) on shares of Tenet Healthcare in a research report on Tuesday, April 15th. Finally, Morgan Stanley initiated coverage on Tenet Healthcare in a report on Wednesday, March 26th. They set an “overweight” rating and a $165.

00 target price on the stock. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.

com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $165.44. Tenet Healthcare Stock Down 1.

8 % Shares of NYSE THC opened at $121.99 on Monday. The company has a quick ratio of 1.

70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25.

The stock has a market capitalization of $11.51 billion, a PE ratio of 3.78, a P/E/G ratio of 1.

02 and a beta of 1.77. The firm has a fifty day moving average of $126.

50 and a 200-day moving average of $136.79. Tenet Healthcare has a 52-week low of $92.

01 and a 52-week high of $171.20. Tenet Healthcare ( NYSE:THC – Get Free Report ) last announced its quarterly earnings data on Wednesday, February 12th.

The company reported $3.44 EPS for the quarter, beating analysts’ consensus estimates of $2.95 by $0.

49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.

88%. Insider Buying and Selling at Tenet Healthcare In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of the business’s stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $125.

43, for a total transaction of $1,194,720.75. Following the completion of the sale, the director now owns 27,378 shares in the company, valued at $3,434,022.

54. The trade was a 25.81 % decrease in their ownership of the stock.

The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link . 0.81% of the stock is currently owned by insiders.

Institutional Inflows and Outflows Hedge funds and other institutional investors have recently modified their holdings of the business. Norges Bank acquired a new position in Tenet Healthcare in the fourth quarter valued at approximately $190,819,000. Wealthfront Advisers LLC bought a new position in Tenet Healthcare during the 4th quarter worth $69,059,000.

Raymond James Financial Inc. bought a new stake in Tenet Healthcare in the fourth quarter valued at $49,001,000. Renaissance Technologies LLC boosted its holdings in shares of Tenet Healthcare by 579.

2% during the fourth quarter. Renaissance Technologies LLC now owns 438,563 shares of the company’s stock valued at $55,360,000 after acquiring an additional 373,988 shares during the period. Finally, Bridgewater Associates LP grew its position in shares of Tenet Healthcare by 225.

4% during the fourth quarter. Bridgewater Associates LP now owns 407,194 shares of the company’s stock worth $51,400,000 after acquiring an additional 282,071 shares during the last quarter. 95.

44% of the stock is owned by institutional investors and hedge funds. Tenet Healthcare Company Profile ( Get Free Report ) Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care.

Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. Featured Stories Five stocks we like better than Tenet Healthcare Canadian Penny Stocks: Can They Make You Rich? Texas Instruments: Earnings Beat, Upbeat Guidance Fuel Recovery Natural Gas Prices Continue To Rally, These Stocks Should Benefit O’Reilly Automotive: An Anytime Buy for Buy-and-Hold Investors 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion Chipotle Mexican Grill Serves Smoking Hot Entry Point in Q2 Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter .

.